Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
They continue to look for growth opportunities globally.
Чем вы больше всего довольны в вашем пакете компенсаций?
Our health, dental, and vision benefits our good!
Что приносит вам больше всего счастья/радости на работе?
Helping patients through collaboration and problem solving and my team.
Каковы самые лучшие качества в вашей команде?
My team is the best! They are hard working, collaborative, fun, and always doing what they can to help patients.
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
My team and my manager are very supportive. We always look to encourage each other and collaborate. My manager cares about me and my personal development.
Other Employee Reviews for Karyopharm Therapeutics
×